Dow Up 1.57% Nasdaq Up 2.12%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
8.17 Up 0.39(5.01%) Jun 28, 4:00PM EDT
Prev Close:7.78
Open:7.94
Bid:N/A
Ask:8.50 x 100
1y Target Est:14.54
Beta:1.81414
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:7.91 - 8.18
52wk Range:6.96 - 25.25
Volume:1,475,826
Avg Vol (3m):1,585,940
Market Cap:1.05B
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HALO

Comparison

Symbol% ChgMkt Cap
HALOUp 5.01%1.05B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.03
Quarterly EPS Est (Jun-16) :-0.27
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback